These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27491687)

  • 1. Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.
    Vergnano S; Buttery J; Cailes B; Chandrasekaran R; Chiappini E; Clark E; Cutland C; de Andrade SD; Esteves-Jaramillo A; Guinazu JR; Jones C; Kampmann B; King J; Kochhar S; Macdonald N; Mangili A; de Menezes Martins R; Velasco Muñoz C; Padula M; Muñoz FM; Oleske J; Sanicas M; Schlaudecker E; Spiegel H; Subelj M; Sukumaran L; Tagbo BN; Top KA; Tran D; Heath PT;
    Vaccine; 2016 Dec; 34(49):6038-6046. PubMed ID: 27491687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHO global vaccine safety multi-country collaboration project on safety in pregnancy: Assessing the level of diagnostic certainty using standardized case definitions for perinatal and neonatal outcomes and maternal immunization.
    Stuurman AL; Sharan A; Jahagirdar S; Elango V; Riera-Montes M; Kashyap N; Biccler J; Poluru R; Arora N; Mathai M; Mangtani P; DeVlieger H; Anderson S; Whitaker B; Wong HL; Cutland C; Guillard Maure C;
    Vaccine X; 2021 Dec; 9():100123. PubMed ID: 34825164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data.
    Schönborn L; Pavord S; Chen VMY; Pai M; Gwarzo DH; Buttery J; Munoz FM; Tran H; Greinacher A; Law B
    Vaccine; 2024 Mar; 42(7):1799-1811. PubMed ID: 38302339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income Countries.
    Watson G; Dodd C; Munoz FM; Eckert LO; Jones CE; Buttery JP; Yildirim IB; Kachikis A; Heath PT; Schlaudecker EP; Bond NH; Santarcangelo PL; Wilcox CR; Bellamy K; Elmontser M; Sienas L; Simon R; Khalil A; Townsend R; Sturkenboom M; Black S
    Pediatr Infect Dis J; 2021 Dec; 40(12):1127-1134. PubMed ID: 34596623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardizing case definitions for monitoring the safety of maternal vaccines globally: GAIA definitions, a review of progress to date.
    Davies HG; Bowman C; Watson G; Dodd C; Jones CE; Munoz FM; Heath PT; Cutland CL; Le Doare K
    Int J Gynaecol Obstet; 2023 Jul; 162(1):29-38. PubMed ID: 37194339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine safety surveillance in Kenya using GAIA standards: A feasibility assessment of existing national and subnational research and program systems.
    Izulla P; Wagai JN; Akelo V; Ombeva A; Okeri E; Onyango D; Omore R; Fuller S; Khagayi S; Were J; Anderson SA; Wong HL; Tippett Barr BA
    Vaccine; 2023 Sep; 41(39):5722-5729. PubMed ID: 37550143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Pathirana J; Muñoz FM; Abbing-Karahagopian V; Bhat N; Harris T; Kapoor A; Keene DL; Mangili A; Padula MA; Pande SL; Pool V; Pourmalek F; Varricchio F; Kochhar S; Cutland CL;
    Vaccine; 2016 Dec; 34(49):6027-6037. PubMed ID: 27449077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key terms for the assessment of the safety of vaccines in pregnancy: Results of a global consultative process to initiate harmonization of adverse event definitions.
    Munoz FM; Eckert LO; Katz MA; Lambach P; Ortiz JR; Bauwens J; Bonhoeffer J
    Vaccine; 2015 Nov; 33(47):6441-52. PubMed ID: 26387433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization in pregnancy safety surveillance in low and middle-income countries- field performance and validation of novel case definitions.
    Kochhar S; Clarke E; Izu A; Emmanuel Kekane-Mochwari K; Cutland CL
    Vaccine; 2019 May; 37(22):2967-2974. PubMed ID: 31014963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: A feasibility assessment.
    Stuurman AL; Riera M; Lamprianou S; Perez-Vilar S; Anderson SA; Mangtani P; Devlieger H; Verstraeten T; Zuber PLF; Guillard Maure C
    Vaccine; 2018 Oct; 36(45):6736-6743. PubMed ID: 30266486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Munoz FM; Cramer JP; Dekker CL; Dudley MZ; Graham BS; Gurwith M; Law B; Perlman S; Polack FP; Spergel JM; Van Braeckel E; Ward BJ; Didierlaurent AM; Lambert PH;
    Vaccine; 2021 May; 39(22):3053-3066. PubMed ID: 33637387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI).
    Bonhoeffer J; Kohl K; Chen R; Duclos P; Heijbel H; Heininger U; Jefferson T; Loupi E
    Vaccine; 2002 Dec; 21(3-4):298-302. PubMed ID: 12450705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Liu YC; Munoz FM; Izurieta HS; Tamborska AA; Solomon T; Law BJ; Chhabra N
    Vaccine; 2023 Mar; 41(11):1902-1910. PubMed ID: 36775774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Carol Liu YC; Ibekwe T; Kelso JM; Klein NP; Shehu N; Steuerwald W; Aneja S; Dudley MZ; Garry R; Munoz FM;
    Vaccine; 2020 Jun; 38(30):4717-4731. PubMed ID: 32418788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory distress in the neonate: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.
    Sweet LR; Keech C; Klein NP; Marshall HS; Tagbo BN; Quine D; Kaur P; Tikhonov I; Nisar MI; Kochhar S; Muñoz FM;
    Vaccine; 2017 Dec; 35(48 Pt A):6506-6517. PubMed ID: 29150056
    [No Abstract]   [Full Text] [Related]  

  • 17. Serious bacterial infections in neonates: improving reporting and case definitions.
    Vergnano S; Seale AC; Fitchett EJA; Sharland M; Heath PT
    Int Health; 2017 May; 9(3):148-155. PubMed ID: 28582556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.
    Schlaudecker EP; Munoz FM; Bardají A; Boghossian NS; Khalil A; Mousa H; Nesin M; Nisar MI; Pool V; Spiegel HML; Tapia MD; Kochhar S; Black S;
    Vaccine; 2017 Dec; 35(48 Pt A):6518-6528. PubMed ID: 29150057
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.
    Kochhar S; Assis DN; Mack C; Izurieta HS; Muratori L; Munoz A; Nordenberg D; Gidudu JF; Blau EF; Vierling JM
    Vaccine; 2024 Mar; 42(7):1812-1825. PubMed ID: 38368225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of adverse events following immunization during pregnancy and the newborn period.
    Fulton TR; Narayanan D; Bonhoeffer J; Ortiz JR; Lambach P; Omer SB
    Vaccine; 2015 Nov; 33(47):6453-65. PubMed ID: 26413879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.